Streamline your clinical trials with automated metadata management
When it comes to efficient clinical study build, content is king. Most importantly: metadata content.…
Certara2024年8月26日
Regulatory requirements for annotated CRFs made easy
aCRFs are a mandatory requirement of the FDA, and therefore a key submission deliverable for…
Certara2024年8月26日
Resmetirom: A pioneering NASH clinical program
Nonalcoholic fatty liver disease (NAFLD) is a condition wherein the liver stores excess fat. Nonalcoholic…
Certara2024年8月23日
Overcoming CMC Challenges in Cell and Gene Therapy: Part I
In this Manufacturing Chemist article, Certara's Drs. Hien Anh Bruno and Deven Shah discuss the…
Certara2024年8月23日
Certara to Participate in Upcoming Investor Conferences
RADNOR, Pa. — 2024年8月21日 -- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in…
Danielle Pillsbury2024年8月21日
Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome
Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome
Cytokine Release Syndrome Cytokine release syndrome (CRS) is an inflammatory immune reaction that clinically manifests…
Certara2024年8月20日
Navigating New Terrain: The Impact of Evolving EU Regulations on Regulatory Affairs
Presentation Materials Don't miss Part 2 in the series Joint Advice on FDA/EMA Compliance…
Danielle Pillsbury2024年8月20日
Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization
The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…
Danielle Pillsbury2024年8月19日
Automation in clinical trials: Why it’s essential for success
Many companies in the life sciences industry are slow to adopt new technologies. This is…
Certara2024年8月19日
